PCP News
July 2011 PCP Newsletter
Hypertrophic Cardiomyopathy: A Review
By Marc L. Odorisi, MD, FACC
Several times a year we hear reports of young athletes dying suddenly during competition. Although there can be many causes, Hypertrophic Cardiomyopathy (HOCM) is a frequent culprit. Let’s spend a moment reviewing this dreaded condition, its presentation, and treatment.
Download the Complete Newsletter
April 2011 PCP Newsletter
What is New in Atrial FIbrillation Management
By Sarah G. Taylor, MD, FACC
What arrhythmia does your patients over age 40 have a 25% lifetime risk of developing? Yes, it is atrial fibrillation (AF), which requires frequent attention in primary care, cardiology, and electrophysiology. There are a substantial number of clinical events affected by atrial fibrillation, including increased rates of death, stroke, heart failure, quality of life, reduced exercise capacity, left ventricular dysfunction, and hospitalizations
Download the Complete Newsletter
Jan 2011 PCP Newsletter
A Closer Look at Peripherial Artery Disease
By David R. Fries, MD, FACC
Peripheral arterial disease (PAD) is most commonly caused by atherosclerosis, which results in impaired blood flow to the upper or lower extremity. PAD is highly associated with systemic atherosclerosis in the coronary and cerebral circulation, which would explain why patients with PAD have a high risk of cardiovascular events including MI, stroke, and vascular death.
Download the Complete Newsletter
Oct 2010 PCP Newsletter
Echocardiogram, Stress Echocardiogram, Dobutamine Echocardiogram What does it all mean?
With so many different cardiac test available it is difficult to know which is the best one to chose for a patient. Here is a brief description of an echocardiogram, a stress echocardiogram and a dobutamine echocardiogram. UCVA will continue to provide articles such as this which will assist you in the management of some of the more common cardiovascular conditions experienced by your patients.
Download the Complete Newsletter
July 2010.PCP Newsletter
Resistant Hypertension at the Office
By Matthew Funderburk, MD, FACC
When assessing cardiovascular risk in patients, hypertension is one of the most common risk factors we encounter, and often one of the most frustrating to manage. Defined as failure to achieve goal BP using full doses of a three-drug regimen including a diuretic, resistant hypertension often can seem an all too common occurrence.
